"How artificial intelligence is changing drug discovery"

by Fleming, Nic (2018)

Abstract

An enormous figure looms over scientists searching for new drugs: the estimated US $2.6- billion price tag of developing a treatment. A lot of that effectively goes down the drain, because it includes money spent on the nine out of ten candidate therapies that fail somewhere between phase I trials and regulatory approval. Few people in the field doubt the need to do things differently.Leading biopharmaceutical companies believe a solution is at hand. Pfizer is using IBM Watson, a system that uses machine learning, to power its …

Links to Reference

• http://dx.doi.org/10.1038/d41586-018-05267-x
• https://www.ncbi.nlm.nih.gov/pubmed/29849160
• https://doi.org/10.1038/d41586-018-05267-x
• https://go.gale.com/ps/i.do?id=GALE%7CA572639347&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=00280836&p=AONE&sw=w

Citation

Share

How to contribute.